Wintest
6721
Showcase
3909
Beauty Kadan Holdings
3041
Cybozu
4776
KODAMA CHEMICAL INDUSTRY
4222
(Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 10.32%637.73B | -0.99%2.46T | 8.11%635.19B | -1.56%630.03B | -5.28%621.32B | -4.59%578.06B | 11.70%2.49T | 1.01%587.53B | 9.61%640.01B | 19.41%655.93B |
Cost of revenue | 7.99%511.18B | -2.29%2.02T | 6.08%519.15B | -3.16%515.4B | -6.75%513.14B | -4.67%473.38B | 15.39%2.07T | 2.85%489.38B | 12.93%532.23B | 24.88%550.3B |
Gross profit | 20.89%126.55B | 5.39%443.52B | 18.22%116.03B | 6.36%114.63B | 2.42%108.18B | -4.21%104.68B | -3.47%420.84B | -7.25%98.15B | -4.28%107.78B | -2.76%105.62B |
Operating expense | 5.47%88.47B | 23.74%385.87B | 47.75%129.75B | 5.79%87.71B | 2.20%84.53B | 43.63%83.89B | -7.03%311.83B | -19.00%87.82B | 5.74%82.91B | 9.47%82.71B |
Selling and administrative expenses | 8.28%89.96B | 4.67%346.34B | 8.34%91.77B | 6.24%87.16B | 3.12%84.34B | 0.86%83.08B | 8.22%330.91B | 4.07%84.7B | 6.70%82.04B | 9.34%81.79B |
-General and administrative expense | 8.28%89.96B | 4.67%346.34B | 8.34%91.77B | 6.24%87.16B | 3.12%84.34B | 0.86%83.08B | 8.22%330.91B | 4.07%84.7B | 6.70%82.04B | 9.34%81.79B |
Other operating expenses | 21.57%3.03B | 225.48%48.51B | 351.48%40.25B | 53.43%2.98B | 46.23%2.8B | 16.65%2.49B | -57.92%14.91B | -69.90%8.91B | -23.31%1.94B | 7.84%1.91B |
Total other operating income | 167.48%4.52B | -73.56%8.99B | -61.04%2.26B | 125.19%2.43B | 162.01%2.61B | -93.53%1.69B | 487.75%33.98B | 124.48%5.8B | 6.51%1.08B | -2.55%995M |
Operating profit | 83.11%38.08B | -47.11%57.65B | -232.75%-13.72B | 8.26%26.92B | 3.22%23.65B | -59.13%20.79B | 8.39%109B | 500.08%10.33B | -27.25%24.87B | -30.71%22.91B |
Net non-operating interest income (expenses) | -29.40%449M | -53.10%-6.93B | -10.37%-2.94B | 54.44%-1.6B | -436.40%-3.04B | -71.12%636M | -1,210.05%-4.53B | -145.12%-2.66B | -460.39%-3.5B | -123.72%-566M |
Non-operating interest income | 2.39%5.19B | 43.20%12.15B | 21.28%1.7B | 380.65%4.15B | -42.62%1.23B | 24.36%5.07B | 27.37%8.48B | 32.67%1.41B | -58.00%863M | 104.98%2.14B |
Non-operating interest expense | 6.95%4.74B | 46.65%19.08B | 14.14%4.64B | 31.56%5.74B | 57.58%4.26B | 136.55%4.43B | 108.11%13.01B | 89.60%4.07B | 303.14%4.37B | 108.64%2.71B |
Net investment income | ||||||||||
Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
Income from associates and other participating interests | -10.82%3.28B | 19.63%8.85B | 98.36%-79M | -25.34%2B | -39.73%3.26B | -11.16%3.68B | -61.75%7.4B | -238.54%-4.82B | -35.52%2.67B | -27.45%5.4B |
Special income (charges) | ||||||||||
Other non-operating income (expenses) | ||||||||||
Income before tax | 66.50%41.8B | -46.75%59.57B | -686.16%-16.74B | 13.66%27.32B | -13.98%23.87B | -56.13%25.11B | -7.02%111.87B | 1,586.98%2.86B | -38.84%24.04B | -31.08%27.75B |
Income tax | 32.52%12B | -6.18%29.11B | 90.88%5.07B | 26.30%8.07B | 0.96%6.92B | -40.17%9.05B | 16.19%31.03B | -34.60%2.65B | -18.47%6.39B | 5.87%6.85B |
Net income | 85.66%29.81B | -62.33%30.46B | -10,946.27%-21.8B | 9.08%19.25B | -18.88%16.95B | -61.86%16.05B | -13.64%80.84B | 104.73%201M | -43.91%17.65B | -38.16%20.9B |
Net income continuous operations | 85.66%29.81B | -62.33%30.46B | -10,946.27%-21.8B | 9.08%19.25B | -18.88%16.95B | -61.86%16.05B | -13.64%80.84B | 104.73%201M | -43.91%17.65B | -38.16%20.9B |
Noncontrolling interests | 39.80%2.95B | 6.76%8.56B | 1.55%1.96B | 11.42%2.46B | 18.98%2.03B | -2.95%2.11B | -14.49%8.02B | 135.20%1.93B | -28.38%2.21B | -34.30%1.71B |
Net income attributable to the company | 92.59%26.86B | -69.93%21.9B | -1,273.53%-23.76B | 8.75%16.79B | -22.25%14.92B | -65.07%13.95B | -13.55%72.82B | 65.88%-1.73B | -45.60%15.44B | -38.48%19.19B |
Preferred stock dividends | ||||||||||
Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net income attributable to common stockholders | 92.59%26.86B | -69.93%21.9B | -1,273.53%-23.76B | 8.75%16.79B | -22.25%14.92B | -65.07%13.95B | -13.55%72.82B | 65.88%-1.73B | -45.60%15.44B | -38.48%19.19B |
Gross dividend payment | ||||||||||
Basic earnings per share | 92.54%16.77 | -69.95%13.67 | -1,274.07%-14.84 | 8.71%10.48 | -22.27%9.32 | -65.08%8.71 | -13.57%45.49 | 65.82%-1.08 | -45.63%9.64 | -38.48%11.99 |
Diluted earnings per share | 92.64%16.74 | -69.93%13.65 | -1,274.07%-14.84 | 8.62%10.46 | -22.31%9.3 | -65.09%8.69 | -13.01%45.4 | 65.82%-1.08 | -45.59%9.63 | -37.69%11.97 |
Dividend per share | 0 | 0.00%18 | 0.00%9 | 0 | 0.00%9 | 0 | 12.50%18 | 12.50%9 | 0 | 12.50%9 |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |